Johnson & Johnson Talcum Powder Cancer Lawsuit: 7,111 Claimants, Asbestos Contamination, and What It Means for US Families
If you are reading this at 2 a.m. because you or someone you love used Johnson & Johnson baby powder for years and then heard the word “cancer,” we want you to know three things before anything else. First: you are not alone — more than 7,000 claimants in a UK case and over 68,000 in the US have made the same connection. Second: the science linking asbestos-contaminated talc to mesothelioma is among the most established in medicine, and the evidence linking perineal talc use to ovarian cancer has produced real plaintiff verdicts in American courtrooms. Third: the clock on your claim may have started the day you were diagnosed, not the day you used the powder — but that clock is real, and the evidence that proves your case is disappearing on its own schedule.
We are Attorney911 — The Manginello Law Firm, PLLC. We are writing this page as a resource for anyone who used J&J talcum powder and developed ovarian cancer or mesothelioma, or who lost a family member who did. We are not counsel in the UK case or the US multidistrict litigation. What we are is a trial firm that has spent more than 27 years in courtrooms fighting for people injured by products they were told were safe, and we know how these cases are built, what the evidence looks like, how the defense tries to make it disappear, and what a family needs to do in the first days and weeks after they connect the powder to the diagnosis.
Call us at 1-888-ATTY-911. The consultation is free, it is confidential, and we do not get paid unless we win your case.
What Happened: The UK Case and the US Parallel Litigation
Public reporting confirms that a product liability action now involving 7,111 claimants is pending in the UK High Court against Johnson & Johnson, alleging the company knowingly sold baby powder contaminated with asbestos. The case began with approximately 3,000 claimants and has more than doubled, positioned to become the largest product liability case in UK history. The claimants allege J&J possessed knowledge as early as the 1960s that its talcum powder contained asbestos contaminants linked to ovarian cancer and mesothelioma, yet marketed the product as a symbol of purity and safety without warning labels. J&J denies all allegations, maintains its product was compliant with regulatory standards, and disputes that the powder contained asbestos or causes cancer.
Here is what the US reader needs to understand: this UK case is not your case. It is a separate proceeding under English product liability law and civil procedure. But it runs parallel to a massive US litigation that may be your path to accountability — and the UK case’s allegations, evidence, and timelines mirror what US courts have been hearing for years.
In the United States, the J&J talc litigation is consolidated as MDL-2738 — In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation in the U.S. District Court for the District of New Jersey before Judge Michael A. Shipp. As of the most recent JPML pending docket report, 68,029 actions were pending in that single federal court. Thousands more cases have been filed in state courts across the country, and bellwether trials in Missouri, California, and other forums have produced significant plaintiff verdicts — some of which have been reduced on appeal, and at least one of which was affirmed by the U.S. Supreme Court’s refusal to intervene.
The UK cessation of talc-based baby powder sales in 2023 mirrors J&J’s US market withdrawal of talc-based products, creating a parallel regulatory and commercial timeline across both jurisdictions. The product you used is no longer being sold — but the harm it may have caused does not have a withdrawal date.
The Allegations: Asbestos Contamination and Decades of Concealment
The claimants in both the UK and US cases allege that J&J knew its talcum powder was contaminated with asbestos — a known human carcinogen — and concealed that knowledge from regulators, the medical community, and consumers while continuing to market the product for daily personal use, including on infants.
The International Agency for Research on Cancer, the world’s leading cancer-science authority, classifies occupational exposure to talc containing asbestos as carcinogenic to humans — its highest category, Group 1. IARC also classifies perineal use of talc-based body powder as possibly carcinogenic. This is not a fringe theory. It is the position of the global cancer research body that governments, courts, and the medical profession rely on.
The International Agency for Research on Cancer classifies occupational exposure to talc containing asbestos as carcinogenic to humans and perineal use of talc-based body powder as possibly carcinogenic.
The mechanism is physical and biological, not speculative. Talc ore and asbestos are geologically intertwined — they form under similar conditions and are often mined from the same deposits. When talc is mined and processed without rigorous purification and testing, asbestos fibers can contaminate the finished product. Those fibers, when inhaled or applied to the body, are what the medical literature describes as near-indestructible — the human body cannot break them down or clear them. They lodge in tissue, cause chronic inflammation and genotoxic damage, and over a latency period that can span decades, produce cancer.
The claimants allege J&J possessed internal testing results and corporate communications dating to the 1960s showing the company knew or should have known about this contamination. The US MDL discovery process has produced extensive internal documents — testing results, executive communications, safety committee minutes, and consultant reports — that form the knowledge timeline at the heart of both the UK and US cases. The gap between when J&J allegedly knew and when any corrective action was taken is the engine that drives not just compensatory damages but punitive damages: decades of alleged knowledge plus alleged concealment is the classic punitive damages pattern.
The Two Cancers: Ovarian Cancer and Mesothelioma
Claimants in the J&J talc litigation present with two distinct cancer types, and the science and the litigation strategy differ for each.
Mesothelioma: The Asbestos Signature Disease
Mesothelioma is a cancer of the lining of the lungs or abdomen that is essentially specific to asbestos exposure. It is so asbestos-specific that the disease itself is near-conclusive proof of exposure — medical literature treats mesothelioma as the signature disease of asbestos, rarely occurring without it. The latency period from first exposure to diagnosis is typically 20 to 50 years, with most cases appearing 30 to 40 years after exposure. Median survival from diagnosis is approximately 12 to 21 months.
For talc claimants, the mesothelioma theory is that asbestos-contaminated talc, inhaled during application or absorbed through perineal use, delivered asbestos fibers to the body just as occupational exposure would. Because mesothelioma’s causal link to asbestos is well-established in the scientific literature, these claims face less contested general causation — the defense cannot credibly argue that mesothelioma comes from nowhere. The battleground is specific causation: proving that THIS exposure (talc use) rather than some other asbestos exposure caused THIS cancer.
The defense exploits the long latency and multiple potential exposure sources. They will argue the mesothelioma came from a different job, a different product, a different building. The counter is product-identification evidence — the claimant’s documented history of J&J baby powder use, the frequency and duration of use, and the absence of other significant asbestos exposures — combined with the fact that the talc product itself, if preserved, can be tested for asbestos contamination through transmission electron microscopy.
Ovarian Cancer: The Contested Causation Battleground
Ovarian cancer is the more common claimant diagnosis in the talc litigation, and it is the more scientifically contested. The theory is that talc particles applied to the perineal area migrate through the reproductive tract to the ovaries, where they cause chronic inflammation that can lead to cancer over time. IARC’s classification of perineal talc use as “possibly carcinogenic” (Group 2B) — not Group 1 — reflects that the scientific evidence is suggestive but not conclusive.
Ovarian cancer is frequently diagnosed at Stage III or IV, when the disease has already spread beyond the ovaries. Treatment typically involves debulking surgery followed by platinum-based chemotherapy, and recurrence rates are high. The five-year survival rate for advanced-stage ovarian cancer remains low, making this a devastating diagnosis for the women who receive it and the families who support them.
The defense in ovarian cancer cases argues that the disease is common in the general population, has multiple known risk factors (genetics, hormonal factors, age, reproductive history), and cannot be attributed to talc use with the certainty the law requires. Plaintiffs counter with epidemiological studies showing elevated risk among long-term perineal talc users, the biological plausibility of the inflammation pathway, and the internal corporate documents showing J&J’s own scientists flagged the concern. This is where expert witness selection becomes decisive — gynecologic oncologists, epidemiologists, and industrial hygienists must build a causation case that survives the defense’s Daubert challenges and stands up to cross-examination.
The Defendant: Johnson & Johnson and the Corporate Shell Game
Johnson & Johnson is one of the largest and most deep-pocketed defendants in American product liability history. But naming the right entity is its own fight, because J&J has deliberately restructured its corporate family to wall off talc liability from its operating assets.
The Corporate Structure
The parent company is Johnson & Johnson, a global pharmaceutical and consumer products conglomerate. The historical talc seller was Johnson & Johnson Consumer Inc. (JJCI). In 2021, J&J executed a controversial corporate restructuring known as a “Texas two-step” divisional merger: it split JJCI into two entities — one that held the consumer business assets and one that held the talc liability. The liability entity was LTL Management LLC, which then filed for Chapter 11 bankruptcy.
That bankruptcy was dismissed. J&J tried again. And again.
On March 31, 2025, the U.S. Bankruptcy Court for the Southern District of Texas denied confirmation and dismissed the Chapter 11 petition of Red River Talc LLC — J&J’s third failed bankruptcy attempt. The court found vote-solicitation irregularities and impermissible nonconsensual third-party releases. Three times the company tried to wall these cases off inside a bankruptcy it created on purpose; three times a court threw it out. The cases are back in the tort system.
J&J also spun off its consumer health business as Kenvue Inc. — a separate public company that now owns brands like Band-Aid, Tylenol, and Listerine. J&J retains indemnity arrangements with Kenvue, but the corporate separation adds another layer to the defendant-identification puzzle.
What This Means for Your Case
The corporate restructuring is not a defense — it is the defense’s strategy. Every layer of corporate separation is a potential argument that “the entity you sued is not the entity that made the product.” A talc case must name the correct operating entity, the correct liability-holding entity, and often the parent company itself, each of which may have different insurance towers, different indemnity obligations, and different exposure to punitive damages. Getting the corporate structure right at the pleading stage is foundational work that a generalist may miss entirely.
The Theories of Liability
US product liability law provides several distinct theories under which a talc cancer claim can proceed. The applicable theories and their elements vary by state, but the core framework is national.
Failure to Warn
J&J allegedly knew for decades that its talc contained asbestos and posed cancer risks, yet marketed the product as pure and safe without any warning on the packaging. The failure-to-warn theory holds that a manufacturer who knows or should know of a danger has a duty to warn consumers. The absence of any warning label on a product marketed for daily personal use — including on infants — is the factual heart of this theory. US courts have consistently held that a manufacturer’s compliance with minimum regulatory standards does not exempt it from common-law liability for failing to warn of known dangers.
Design Defect
The product was unreasonably dangerous because talc, as formulated and sourced, was susceptible to asbestos contamination that could have been eliminated through alternative formulations (such as cornstarch-based powder, which J&J eventually adopted) or more rigorous testing and purification protocols. The design-defect theory asks whether a safer, feasible alternative design existed and whether the defendant’s failure to adopt it rendered the product not reasonably safe.
Manufacturing Defect
Asbestos contamination of the talc during mining, processing, or manufacturing rendered the product unreasonably dangerous when it left J&J’s control. This theory focuses on the specific production process — how the raw talc ore was sourced, how it was processed, what testing was performed, and what quality controls were in place to detect and remove asbestos contamination.
Fraudulent Concealment
J&J allegedly concealed internal knowledge of asbestos contamination from regulators, consumers, and the medical community while continuing to market the product for daily personal use. This theory is the punitive damages engine. If a jury finds that J&J knew its product was contaminated, knew it posed cancer risks, and deliberately concealed that information, the temporal gap between knowledge (allegedly the 1960s) and any corrective action becomes evidence of conscious disregard — the legal predicate for punishment damages.
Negligent Marketing
J&J promoted a product containing known carcinogens for intimate daily use — perineal application on adults and infants — without adequate safety testing or risk disclosure. The marketing of baby powder as a “symbol of purity and safety,” as claimants have described it, is the factual anchor: a company that markets purity while allegedly concealing contamination has made a choice that a jury can evaluate.
The Evidence Clock: What Exists and How Fast It Disappears
Every product liability case lives or dies on evidence, and talc cancer cases face a unique evidence challenge: the exposure may have occurred decades ago, the product is no longer sold, and the corporate documents that prove knowledge are in the defendant’s control. Here is what exists, who holds it, and how fast it can legally die.
Preserved Product Samples
If you still have a container of J&J baby powder containing talc — your own, a family member’s, or one stored in a bathroom cabinet — that container is evidence. Through transmission electron microscopy, a forensic analytical chemist can determine whether the talc in that specific container contains asbestos fibers and at what concentration. This is the single most powerful piece of specific-causation evidence a talc claimant can produce: a laboratory analysis of the actual product the claimant used, showing it contained asbestos.
The product is no longer sold. Remaining consumer-held samples are finite and degrading. If you have a container, do not discard it, do not open it unnecessarily, and do not transfer the contents. Store it in a sealed container in a dry location and tell your lawyer about it immediately.
J&J Internal Corporate Documents
The US MDL has produced extensive document discovery — internal testing results, executive communications, safety committee minutes, and consultant reports establishing the knowledge timeline. These documents are the spine of the knowledge-plus-concealment narrative that drives punitive damages. However, document retention policies, corporate restructuring, and the passage of decades mean that some records may have been destroyed in the ordinary course of business. The UK case is separately seeking UK-specific document production.
Medical Records and Pathology Specimens
Your medical records link your specific cancer diagnosis and subtype to your talc exposure history. Pathology specimens — tissue blocks from biopsies or surgeries — can sometimes be analyzed for talc particles or asbestos fibers, providing direct physical evidence of exposure. Hospitals routinely archive pathology specimens, but retention periods are finite — typically 7 to 10 years after the procedure, though this varies by institution and state law. If you or a family member had cancer surgery or biopsy, the pathology blocks may still exist, but they are on a clock.
Talc Mining and Supply Chain Records
The raw talc ore used in J&J baby powder came from specific mines, and the geological characteristics of those mines — including the presence of asbestos deposits — are discoverable. Supply chain records tracing specific ore shipments to specific product batches can establish that contaminated talc entered the manufacturing stream. Mine operators may cease operations, destroy records, or face corporate dissolution, making these records irreplaceable.
Historical Marketing and Advertising Materials
J&J’s marketing of baby powder as pure and safe — without warnings — is the factual foundation of the failure-to-warn and fraudulent concealment theories. Historical advertising archives, packaging designs, and promotional materials must be systematically collected. Some of this material is in public archives; some is in J&J’s own marketing files, discoverable through litigation.
FDA Testing Records and Regulatory Correspondence
The FDA has conducted testing that identified asbestos in certain talc samples, prompting recalls. FDA testing records, recall notices, and regulatory correspondence with J&J are publicly available and corroborate the regulatory timeline. The FDA regulates cosmetic products including talcum powder but does not require premarket approval, and historically did not mandate asbestos testing for cosmetic-grade talc — a regulatory gap that J&J’s defense may point to as compliance with applicable standards, but that does not exempt the company from common-law liability.
The FDA Regulatory Framework: Why “Compliant” Does Not Mean “Safe”
One of J&J’s stated defenses is that its baby powder “was compliant with any required regulatory standards.” Here is why that defense is legally insufficient under US product liability law.
The FDA regulates cosmetic products under the Federal Food, Drug, and Cosmetic Act, but cosmetics do not require premarket approval in the way drugs and medical devices do. The FDA historically did not mandate asbestos testing for cosmetic-grade talc. This means a cosmetic company could sell talc-based powder without independently testing it for asbestos contamination and still be technically “compliant” with FDA requirements.
But US product liability law does not treat regulatory compliance as a safe harbor. Under the express savings clause of the National Traffic and Motor Vehicle Safety Act and the analogous principles that apply across product liability law, compliance with a federal safety standard does not exempt a manufacturer from liability at common law. A company that meets the minimum regulatory floor has done the least the law requires — it has not done what a reasonable manufacturer should do to protect consumers from a known danger.
The defense will say “we met the standard.” The answer is that the standard was a floor, not a ceiling, and a company that knew its product contained a known human carcinogen had a duty that exceeded any regulatory minimum — a duty to warn, to test, and to protect the people who trusted the brand name on the bottle.
The US Multidistrict Litigation: Where Your Case Would Live
If you file a talc cancer claim in US federal court, it will likely be transferred to MDL-2738 in the District of New Jersey before Judge Shipp. As of the most recent JPML report, 68,029 actions were pending in that court. Joining the MDL does not merge your case into one big pot — you keep your own claim, your own damages, and your own right to trial. The MDL centralizes pretrial proceedings — discovery, motion practice, expert challenges — so that the shared factual questions are litigated once rather than thousands of times.
The MDL has produced extensive discovery, including the internal J&J documents that establish the knowledge timeline. Bellwether trials — test cases selected to go to trial first — have produced significant plaintiff verdicts in state courts. In 2018, a Missouri jury returned a verdict of $4.69 billion against J&J in a case involving 22 women who claimed talc caused their ovarian cancer. That verdict was reduced on appeal to approximately $2.12 billion, and in June 2021, the U.S. Supreme Court declined to review the case, leaving the reduced award in place. That is not a press release — it is a number the highest court in the country let stand.
Not every verdict has survived. The bellwether record is mixed, with some verdicts reduced on appeal and some reversed. The defense has aggressively challenged expert testimony on general causation for ovarian cancer, and the scientific debate over the talc-ovarian cancer link continues. Mesothelioma claims, with their well-established asbestos causation, face fewer causation hurdles.
The Statute of Limitations: When the Clock Starts
This is the single most important legal question for most talc claimants, and the answer is different from what most people assume.
For latent disease claims — cancers that develop years or decades after exposure to a carcinogen — most US jurisdictions apply a discovery rule. Under this rule, the statute of limitations does not begin running on the date you used the product. It begins running when you discovered, or by reasonable diligence should have discovered, that you had an injury AND that the injury was caused by the defendant’s product.
For many talc claimants, that date is the date of their cancer diagnosis — or potentially the date they first learned of a possible connection between talc and their cancer. This means a woman diagnosed with ovarian cancer in 2023 who used J&J baby powder for 30 years may still be within the filing window even though her exposure ended decades ago.
However, the specific limitations period varies by state — some states have two-year limitations, others three or more — and some states impose an outer deadline called a statute of repose that can cut off a claim even before discovery. You cannot determine your deadline without consulting an attorney in your jurisdiction, and you should not wait to do so. The deadline that applies to you is the law of the state where you live or where the exposure occurred, and we confirm the current rule for your specific situation when you call.
For wrongful death claims — where a family member who used talc has already died from cancer — a separate limitations clock typically runs from the date of death, not the date of exposure or even the date of diagnosis. If your mother, wife, sister, or partner died from ovarian cancer or mesothelioma and used J&J baby powder, the clock on a wrongful death claim may have started on the day she passed. This deadline is often shorter than the personal injury deadline, which makes urgency even greater for families who have already lost someone.
Case Value: What These Cases Are Worth
We will be honest with you about what we know and what we cannot promise.
Individual US talc cancer claims range widely in value depending on the cancer type, the strength of the exposure history, the jurisdiction, the defendant’s conduct, and whether the case is part of a mass settlement or an individual trial. Based on the litigation landscape and the verified outcomes in the US MDL and state court bellwether trials:
Mesothelioma claims typically command higher individual values because the asbestos causation link is well-established and the disease course is aggressive and well-documented. These claims may range from hundreds of thousands to several million dollars or more per individual case, depending on the factors above.
Ovarian cancer claims face more contested general causation but have produced significant plaintiff verdicts in US courts. The reduced and affirmed verdict in the Missouri bellwether case — approximately $2.12 billion across 22 plaintiffs — demonstrates that juries are willing to return substantial awards when the evidence of knowledge and concealment is strong. Individual claim values vary widely based on diagnosis stage, treatment history, age, earning capacity, and the specific evidence of the claimant’s talc use.
Punitive damages are a central driver of value in these cases. The decades-long gap between J&J’s alleged knowledge (the 1960s) and any corrective action — combined with internal documents that may show conscious concealment — is the classic punitive damages engine. Whether punitive damages are available, and whether they are capped, depends on the law of the state where the case is filed. Some states cap punitive damages; others do not. Some states have had their caps struck down by their supreme courts. This is a volatile area of law that must be confirmed for the specific jurisdiction.
Mass tort settlement values often resolve at a discount compared to individual trial verdicts because of volume aggregation — a global settlement that resolves thousands of cases will typically pay less per claimant than a single plaintiff verdict. But the trade-off is certainty, speed, and the avoidance of trial risk. Whether your case is better suited for the MDL settlement track or for an individual trial is a strategic decision that depends on your specific facts, your cancer type, your exposure history, and your personal priorities.
Past results depend on the facts of each case and do not guarantee future outcomes. We will not promise you a number. What we will do is give you an honest, evidence-based evaluation of what your case is worth based on your specific facts, the applicable law, and the current state of the litigation.
The Defense Playbook: What J&J Will Do and How We Counter
Lupe Peña spent years inside a national insurance-defense firm before coming to our side of the table. He sat in the rooms where adjusters and their software decided how to deny, delay, and devalue claims from people exactly like you. He knows the playbook from the inside, and we use that knowledge to protect our clients. Here are the plays J&J’s legal team and insurers have deployed, and the counter to each.
Play 1: “The Product Did Not Contain Asbestos”
J&J’s public position is that its baby powder did not contain asbestos. This is the foundational defense, and it is directly contradicted by the claimants’ evidence — internal testing results, independent laboratory analyses of preserved product samples, and the testimony of analytical chemists who have examined J&J talc under transmission electron microscopy. The counter is the product itself: if the claimant has a preserved container, it can be tested. If the claimant does not, the US MDL has produced internal J&J testing documents that the claimants’ experts say show the company’s own scientists found asbestos in the talc. The defense will challenge the testing methodology, the sample chain of custody, and the interpretation of the results — which is why the analytical chemistry expert selection is one of the most important decisions in the case.
Play 2: “Talc Does Not Cause Ovarian Cancer”
For ovarian cancer claimants, the defense argues that the scientific evidence does not establish that perineal talc use causes ovarian cancer. They cite studies that find no link, challenge the epidemiological methodology of studies that do, and file Daubert motions to exclude the plaintiffs’ expert witnesses. The counter is a robust causation case built on multiple pillars: the IARC classification, the biological plausibility of the inflammation pathway, epidemiological studies showing elevated risk, and the internal corporate documents showing J&J’s own scientists flagged the concern. The defense’s causation challenge is real — the science is genuinely contested — and any lawyer who tells you the ovarian cancer causation is settled is not being straight with you. What is true is that juries have heard the evidence and returned plaintiff verdicts, which means the science, while contested, is strong enough to win.
Play 3: Oppressive Discovery Requests
Public reporting from the UK case confirms that J&J’s lawyers have served discovery requests that claimants’ counsel describes as “tantamount to a full witness statement from each claimant” and “consistent with an intention to be onerous to the point of oppression” — designed to stifle the litigation by burying claimants in paperwork. J&J’s lawyers respond that the requests are “reasonable and fair” and “neither oppressive nor intended to stifle the claims.” This is a standard defense playbook move in mass tort litigation: make the burden of participating so high that claimants give up or settle for less. The counter is procedural — motion practice to limit discovery to what is relevant and proportional, protective orders, and the coordination of mass tort counsel to share the burden across thousands of claimants rather than forcing each to fight alone.
Play 4: The Bankruptcy Shell Game
J&J has now tried three times to use a corporate restructuring strategy — creating a subsidiary to absorb talc liabilities and filing that entity for bankruptcy — to cap its exposure and force claimants into a settlement fund administered by a bankruptcy court rather than a jury. Three times, courts have rejected the strategy. The most recent dismissal, on March 31, 2025, found vote-solicitation irregularities and impermissible nonconsensual third-party releases. J&J appears to have pivoted to defending cases in the tort system, but the bankruptcy strategy could resurface. The counter is vigilance — any attempt to channel claims into a bankruptcy proceeding must be challenged, and claimants must be represented by counsel who understands the bankruptcy-tort intersection.
Play 5: Blame the Victim or Find Another Cause
The defense will look for alternative explanations for the cancer: genetic predisposition (BRCA mutations for ovarian cancer), other asbestos exposures (for mesothelioma), hormonal factors, reproductive history, age, lifestyle. This is not unique to talc litigation — it is the standard defense playbook in every toxic tort case. The counter is the eggshell-plaintiff doctrine, which holds that a defendant takes the victim as found — a pre-existing vulnerability that made the harm worse does not reduce the defendant’s liability. The counter is also thorough exposure and medical history: documenting the claimant’s talc use in detail, ruling out or accounting for other exposures, and building a specific-causation case that ties this cancer to this product.
How a Talc Cancer Case Is Actually Built
Here is how a case like this moves from intake to resolution — not a summary, but the walk.
Week One: Intake and Evidence Preservation
The day you call, we begin. We take your full exposure history — when you started using J&J baby powder, how often, for how long, where on your body, whether you used it on your children. We document your medical history — the diagnosis date, the cancer type and stage, the treatment you have received, your treating physicians, your prognosis. We identify and locate any preserved product containers. We send preservation letters — to J&J, to any testing laboratories, to any third parties who may hold relevant records — ordering them to freeze evidence before it can be legally destroyed. If you have a pathology specimen from a biopsy or surgery, we work to secure it before the hospital’s retention period expires.
Weeks Two Through Eight: Medical Records and Expert Review
We pull your complete medical record — pathology reports, imaging, treatment summaries, surgical notes, chemotherapy records. We secure your pathology blocks if they still exist. We retain the right experts: for mesothelioma, an asbestos analytical chemist to test preserved product samples and a pulmonary pathologist to review tissue specimens; for ovarian cancer, a gynecologic oncologist and an epidemiologist to build the causation case; for both, an industrial hygienist to reconstruct the exposure pathway from perineal talc application to tissue absorption. We review the internal J&J documents already produced in the MDL to identify the specific testing results, executive communications, and safety committee minutes that establish the knowledge timeline for your case.
Months Two Through Six: Filing and Discovery
Your case is filed — in federal court (likely transferring to the MDL) or in state court, depending on the strategy that best serves your facts. If you are joining the MDL, your case is filed in your home district and then transferred to the District of New Jersey for pretrial proceedings. The complaint pleads the specific theories of liability — failure to warn, design defect, manufacturing defect, fraudulent concealment, negligent marketing — and names the correct J&J entities. Discovery begins: we demand the internal documents, the testing records, the marketing materials, the supply chain data. We serve interrogatories and take depositions of J&J’s corporate representatives — the scientists who tested the talc, the executives who made the marketing decisions, the regulatory affairs staff who communicated with the FDA.
Months Six Through Resolution: Motions, Mediation, Trial
The defense will file motions to exclude your expert witnesses under Daubert — arguing that the scientific evidence is unreliable. We defend the experts with their credentials, their methodology, and the peer-reviewed literature. The defense may file motions for summary judgment — arguing that the evidence is insufficient to go to a jury. We defeat them with the specific facts of your case, the internal documents, and the expert testimony. If the case does not settle — and many do, through the MDL settlement framework or individual mediation — it goes to trial. A jury hears the evidence: the decades of alleged knowledge, the marketing of purity, the cancer diagnosis, the human cost. The jury decides.
This is not a fast process. Public reporting from the UK case notes that “it is likely to be years before the case concludes.” The US MDL has been pending since 2016. But the process moves — and your place in it is secured the day you file.
The First 72 Hours: What to Do Right Now
If you or a family member used J&J baby powder containing talc and has been diagnosed with ovarian cancer or mesothelioma, here is what we recommend you do in the first days.
First: Focus on your medical care. Your health and your treatment come before anything else. The legal case exists to support you, not to compete with your medical needs. Keep all your appointments. Follow your treatment plan. Keep copies of every medical record, every test result, every imaging report, every pathology report — these are the documents that prove your injury.
Second: Document your product use history. Write down everything you can remember about your use of J&J baby powder: when you started, how often you used it, where on your body you applied it, whether you used it on your children, when you stopped, and whether you still have any containers. Ask family members — parents, siblings, partners — what they remember. This exposure history is the foundation of your specific-causation case, and memories fade.
Third: Preserve any remaining product containers. If you have a bottle of J&J baby powder containing talc, store it in a sealed container in a dry location. Do not throw it away. Do not open it or use it. Do not transfer the contents. This container can be laboratory-tested for asbestos contamination, and it may be the single most important piece of physical evidence in your case.
Fourth: Do not sign anything from J&J, its insurers, or any claims administrator. Do not give a recorded statement. Do not accept a quick settlement check. Do not post about your case on social media. The defense is watching, and anything you say can be used against you.
Fifth: Call a lawyer. The consultation is free. The preservation letters that freeze the evidence go out the day you hire counsel. The statute of limitations clock is running. The pathology specimens are on a hospital retention schedule. The product containers are finite. Every day you wait is a day the evidence gets older and the clock gets shorter.
Call us at 1-888-ATTY-911. We answer 24 hours a day, 7 days a week — not an answering service, live staff. We serve your family fully in English or in Spanish.
The Medicine: What These Cancers Do to a Family
We are not doctors, and this page is legal information, not medical advice. But we have sat with families through the trajectory of both of these cancers, and we know what the medical record shows and what the family watches happen.
Ovarian cancer is often called a “silent killer” because its early symptoms — bloating, pelvic pain, urinary frequency, feeling full quickly — are vague and easily attributed to other causes. By the time most ovarian cancers are diagnosed, the disease has spread beyond the ovaries. Treatment involves surgery to remove as much of the tumor as possible (debulking), followed by chemotherapy, typically platinum-based drugs like carboplatin or cisplatin. Recurrence is common — the cancer may go into remission and then return, requiring additional rounds of treatment. For the family, this means months and years of surgery, chemo, scans, waiting for results, hope, and setback — a cycle that is physically and emotionally exhausting for the patient and for everyone who loves her.
Mesothelioma is different but no less devastating. It is a cancer of the thin membrane that lines the lungs or the abdomen, and it is essentially caused by one thing: asbestos. The latency is the cruelest part — 20 to 50 years may pass between the exposure and the diagnosis, meaning a woman who used baby powder in her twenties may not develop mesothelioma until her sixties or seventies. By then, the disease is advanced. Treatment may include surgery to remove the pleural lining, chemotherapy, radiation, and increasingly, immunotherapy. But median survival remains short — measured in months to a couple of years. For the family, the trajectory is steep: diagnosis, aggressive treatment, decline, and loss, often within 12 to 24 months.
The public reporting from the UK case carries a statistic that we want you to hear honestly: one claimant is dying from their cancer every three days. That is the pace at which this litigation is outliving the people it is meant to compensate. Margaret Manion, from Longfield in Kent, signed up to the UK claim in late 2024. She was diagnosed with ovarian cancer in April 2024 and died in November 2025, aged 73. Her partner of 30 years described her diagnosis as a “bombshell” and said the two years of her illness “were the most painful experience ever, for Margaret and her family.” Her story — a mother who was dusted with baby powder as an infant and continued using it daily through adulthood and on her own children — mirrors thousands of other claimants. We speak of her with respect and restraint, because her story is the reason this litigation exists.
If your family has been through this, or is going through it now, the legal case exists to hold the company accountable and to recover the resources your family needs. But it also exists to force the truth into the public record — the testing results, the internal memos, the decades of knowledge — so that what happened to your family does not happen in silence.
Frequently Asked Questions
Can I still file a talcum powder lawsuit if I was diagnosed years ago?
It depends on your state’s statute of limitations and the discovery rule. For latent disease claims like cancer, most states start the clock when you discovered or should have discovered that your injury was connected to the product — not when you used the product. If you were diagnosed with ovarian cancer or mesothelioma and only recently learned of a possible connection to talcum powder, you may still be within the filing window. However, every state has a different deadline, and some have outer limits called statutes of repose that can cut off a claim regardless of discovery. You need to confirm the deadline for your specific state with an attorney immediately.
I used generic or store-brand baby powder, not J&J. Can I still sue?
Potentially, yes — but the defendant would be different. If you used a store-brand or generic talcum powder, the manufacturer of that product would be the defendant, not J&J. The same legal theories — failure to warn, design defect, asbestos contamination — may apply. However, the internal corporate documents that have made the J&J case so powerful may not exist for other manufacturers, and the defendant’s resources and insurance coverage may be different. If you used multiple brands over the years, documenting which brands you used and when is critical.
Does the UK case affect my US claim?
No. The UK case is a separate proceeding under English law in the UK High Court. Your US claim would proceed under US product liability law in a US court — likely the MDL in the District of New Jersey if filed in federal court, or in a state court depending on your jurisdiction. However, the UK case’s allegations, evidence, and timelines are relevant because they arise from the same product and the same alleged corporate conduct. The US MDL has its own discovery, its own bellwether trials, and its own settlement framework.
What if my family member who used the powder has already died?
You may have a wrongful death claim. Wrongful death statutes allow surviving family members — typically spouses, children, and sometimes parents — to recover for the loss of their loved one. Each state defines who may bring a wrongful death claim and what damages are recoverable. The statute of limitations for wrongful death typically runs from the date of death, not the date of exposure or diagnosis, and this deadline is often shorter than the personal injury deadline. If your family member died from ovarian cancer or mesothelioma and used J&J baby powder, you should consult an attorney about a wrongful death claim as soon as possible. You can learn more on our wrongful death claims page.
How long does a talcum powder lawsuit take?
Mass tort litigation is not fast. The US MDL has been pending since 2016. Individual cases may resolve through settlement in months to a few years, or may go to trial, which can take longer. Public reporting from the UK case states it is likely to be years before that case concludes. The timeline depends on whether your case settles through the MDL framework, goes to individual trial, or is part of a global resolution. Your health and age may affect the timeline — courts can sometimes expedite cases for claimants who are gravely ill, a process called a motion to prefer.
What evidence do I need to prove my case?
The strongest evidence includes: any preserved product containers (which can be laboratory-tested for asbestos), your medical records (diagnosis, pathology, treatment), your documented history of product use (when, how often, how long, where on your body), and any pathology specimens from biopsies or surgeries (which can sometimes be analyzed for talc or asbestos particles). The internal J&J documents already produced in the MDL — testing results, executive communications, marketing materials — are available to all MDL plaintiffs. Your job is to preserve your personal evidence; the corporate documents are already in the litigation pipeline. Learn more about our approach on our toxic tort claims page.
Is there a settlement available for talc claims?
The US MDL has settlement frameworks for certain categories of claims, and J&J has indicated a pivot to resolving cases in the tort system after its third bankruptcy attempt failed. However, not every claimant qualifies for every settlement, and settlement values vary widely based on cancer type, exposure history, diagnosis stage, and other factors. Some claimants achieve better outcomes through individual trial rather than settlement. Whether settlement or trial is the right path for you depends on your specific facts and priorities. We will give you an honest assessment of both options.
What if I smoked or had other risk factors for cancer?
The defense will look for alternative causes — and they should, because that is their job. But the eggshell-plaintiff doctrine, which is recognized in nearly every US jurisdiction, holds that a defendant takes the victim as found. A pre-existing vulnerability that made the harm worse does not reduce the defendant’s liability. If you have other risk factors for ovarian cancer or mesothelioma, the defense will argue those factors — not the talc — caused your cancer. The counter is a thorough specific-causation analysis by qualified experts who can rule out or account for alternative causes and tie your cancer to your talc exposure based on the dose, duration, and timing of your product use.
Who We Are and Why It Matters
We are Attorney911 — The Manginello Law Firm, PLLC. We are a Houston-based trial firm that takes toxic tort, product liability, and wrongful death cases across the country. We work with local counsel and appear pro hac vice where required, and we have the resources and the experience to take on a defendant the size of Johnson & Johnson.
Ralph P. Manginello is our Managing Partner. He has been licensed to practice law in Texas since November 6, 1998 — more than 27 years. He is admitted to the U.S. District Court for the Southern District of Texas, including the Bankruptcy Court. He was a journalist before he was a lawyer, which means he knows how to find a story in a document and how to tell it to a jury. He is a member of the Texas Trial Lawyers Association, the Houston Bar Association, and the Trial Lawyers Achievement Association — Million Dollar Member. He leads our active $10 million hazing lawsuit against Pi Kappa Phi and the University of Houston, filed in Harris County in November 2025.
Lupe Peña is our Associate Attorney. He was licensed in Texas in December 2012 and is admitted to the U.S. District Court for the Southern District of Texas. Before he came to our side, Lupe spent years at a national insurance-defense firm — the rooms where adjusters and their software decided how to deny, delay, and devalue claims from people exactly like you. He knows how the other side values a claim, how they pick their experts, how they conduct surveillance, and how they engineer recorded statements. He now uses that inside knowledge for injured clients. He is fluent in Spanish and conducts full client consultations in Spanish without an interpreter.
Our fee is contingency. We charge 33.33% before trial and 40% if the case goes to trial. We do not get paid unless we win your case. The consultation is free. We answer our phones 24 hours a day, 7 days a week with live staff — not an answering service. Call 1-888-ATTY-911.
Hablamos Español. Lupe conducts full consultations in Spanish, and our bilingual staff serves your family in the language you are most comfortable speaking.
You can learn more about Ralph on his attorney bio page and about Lupe on his bio page. You can also explore our full practice areas to see the range of cases we handle.
The Decision That Matters
If you or someone you love used Johnson & Johnson baby powder containing talc and developed ovarian cancer or mesothelioma, you are standing at a decision point. The evidence is disappearing — preserved product containers are finite, pathology specimens are on hospital retention schedules, and the statute of limitations clock is running. The UK case has shown that the litigation is growing, not shrinking — from 3,000 to 7,111 claimants — and that one claimant is dying every three days while the case proceeds. The US MDL has shown that juries will return substantial verdicts when the evidence of knowledge and concealment is strong, and that the highest court in the country will let those verdicts stand.
But none of that helps you if your claim is not filed. None of it preserves your evidence. None of it stops the clock.
The call is free. The consultation is confidential. We do not get paid unless we win. And if we are not the right fit for your case, we will tell you — and we will help you find the firm that is.
Call 1-888-ATTY-911. Or call our direct line at (713) 528-9070. We answer 24 hours a day.
Past results depend on the facts of each case and do not guarantee future outcomes. This page is legal information, not legal advice. Every case is different, and the outcome of your case depends on the specific facts, the applicable law, and the decisions you make. Contacting the firm is free and confidential.